Michael P. Stansky - 04 Feb 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Michael P. Stansky
Issuer symbol
TLSI
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
4
Filing time
11 Feb 2026, 18:51:12 UTC
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stansky Michael P Director 6272 W. 91ST AVENUE, WESTMINSTER /s/ Michael P. Stansky 11 Feb 2026 0001424204

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Director Stock Option (right to buy) Award $0 +92,537 $0.000000 92,537 04 Feb 2026 Common Stock 92,537 $4.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vest in three equal annual installments commencing on February 4, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.